Skip to main content
Signal8

LENSAR, Inc. (LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

LENSAR Inc logo

LENSAR Inc

NASDAQ:LNSRHealthcare
-2.18%$5.84
AH$5.84+0.00%vs close
Mkt Cap$71.75M
Float9.03M
O/S12.29M
Vol
$ Vol
RVOL
Inst Own35.8%
SI3.4%
Earnings
Dilution
Pipeline4 lead-sponsored trials·0 active1 completed(2 more as collaborator)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 2/3
    Unknown status

    Laser Treatment of the Crystalline Lens

    LensAR laser surgery, Phaco-emulsification cataract surgery

    Cataract

    Enrollment
    75
    Start
    Oct 2008
    Primary Completion
    Oct 2009
    Completion
    Apr 2011est.
    NCT01001117
  • Phase 2/3
    Unknown status

    Prospective Clinical Trial of the LensAR Laser System

    LensAR Laser System, Conventional phacoemulsification

    Cataract

    Enrollment
    100
    Start
    Nov 2009
    Primary Completion
    Jun 2011est.
    Completion
    Jun 2011est.
    NCT01014702
  • Not applicable
    Terminated

    Feasibility Study of Laser Treatment of the Crystalline Lens to Correct Presbyopia

    LensAR Laser System

    Presbyopia, Cataract

    Enrollment
    80
    Start
    Dec 2009
    Primary Completion
    Oct 2011
    Completion
    Oct 2011
    NCT01062412
  • Observational
    Completed

    Retrospective Analysis of the Time Elements for Different Workflow Scenarios During Femtosecond Laser-assisted Cataract Surgery (FLACS) From the Surgeon, Staff, and Patient Perspectives.

    workflow

    Cataract

    Enrollment
    46
    Start
    Jun 2023
    Primary Completion
    May 2024
    Completion
    Jun 2024
    NCT07038395